This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

RAN-RISPERIDONE

RANBAXY PHARMACEUTICALS CANADA INC.

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RAN-RISPERIDONE in Canada?

Yes. RAN-RISPERIDONE 2.0MG has an active shortage reported to Health Canada (last updated November 11, 2025).

Why is RAN-RISPERIDONE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will RAN-RISPERIDONE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 5 same form & route

Affected strength2.0MG

Report last updated2020-02-02

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MINT-RISPERIDON

MINT PHARMACEUTICALS INC

2.0MG · DIN 02359820

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

APO-RISPERIDONE

APOTEX INC

0.25MG · DIN 02282119

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-RISPERIDONE

PHARMASCIENCE INC

1MG · DIN 02279266

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

JAMP-RISPERIDONE

JAMP PHARMA CORPORATION

0.25MG · DIN 02359529

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RISPERIDONE

SANIS HEALTH INC

4MG · DIN 02356937

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-RISPERIDONE

PRO DOC LIMITEE

0.25MG · DIN 02312700

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02328348

Strength

2.0MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

RISPERIDONE

Tier

Unrated

Last Updated

2020-02-02

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

RAN-RISPERIDONE has 2 shortage/discontinuation reports on file — this is one of them.

2025-11-11

Active Shortage

Disruption of the manufacture of the drug.

Other Products from RANBAXY PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

RAN-CITALO

40MG · DIN 02285630

RAN-CITALO

20MG · DIN 02285622

RAN-FENTANYL MATRIX PATCH

75MCG · DIN 02330148

RAN-FENTANYL MATRIX PATCH

100MCG · DIN 02330156

RAN-FENTANYL MATRIX PATCH

12MCG · DIN 02330105

RAN-FENTANYL MATRIX PATCH

50MCG · DIN 02330121